New Delhi, Nov. 5 -- Sun Pharmaceutical Industries on Wednesday reported a consolidated net profit of Rs.3,117.95 crore in the second quarter of FY26, registering a growth of 2.55% from Rs.3,040.16 crore in the year-ago period.

The company's total revenue from operations in Q2FY26 increased nearly 9% to Rs.14,478.31 crore from Rs.13,291.39 crore, year-on-year (YoY).

(More to come)

Published by HT Digital Content Services with permission from MINT....